PPBT Dividende : Purple Biotech Ltd Analyse du rendement



Dividendes

PPBT Dividendes

Purple Biotech Ltd

$4.12

5.49%

$0.21

À la fermeture : May 08, 16:00:00 GMT-4

$3.95

-4.24%

$-0.17

Post-Marché: May 08, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$3.91

Prix d'ouverture

$4.08

Plage de la journée

$3.95 - $4.19

Plage de 52 semaines

$3.6 - $29

Volume

3.3K

Volume moyen

13.3K

Rendement en dividend

BPA (TTM)

-54.00

Capitalisation boursière

$3.6M

Qu’est-ce que Purple Biotech Ltd. ?

Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.